Extended dual antiplatelet therapy after acute myocardial infarction. Current evidence and future perspectives
نویسندگان
چکیده
منابع مشابه
Current status and future prospects for acute myocardial infarction therapy.
Considerable new evidence has accumulated in randomized trials of myocardial reperfusion. The trials of catheter-based reperfusion compared with fibrinolytics have shown an advantage for angioplasty and stenting over pharmacologic therapy, even accounting for delays in transporting patients from facilities with intervention capabilities. On the basis of the recent trials, it is recommended that...
متن کاملTriple vs. dual antiplatelet therapy in patients with acute myocardial infarction and renal dysfunction.
BACKGROUND The question as to whether triple antiplatelet therapy is superior to dual antiplatelet therapy for patients with acute myocardial infarction (AMI) and renal dysfunction, who undergo percutaneous coronary intervention (PCI), is unresolved. METHODS AND RESULTS As part of the Korea Acute Myocardial Infarction Registry (KAMIR), 2,288 AMI patients with renal dysfunction (glomerular f...
متن کاملInitiation and persistence with dual antiplatelet therapy after acute myocardial infarction: a Danish nationwide population-based cohort study.
OBJECTIVES The study investigated dual antiplatelet therapy (DAPT) patterns over time and patient characteristics associated with the various treatments in a myocardial infarction (MI) population. DESIGN A registry-based observational cohort study was performed using antecedent data. SETTING This study linked morbidity, mortality and medication data from Danish national registries. PARTIC...
متن کاملPeripartum management of dual antiplatelet therapy and neuraxial labor analgesia after bare metal stent insertion for acute myocardial infarction.
A 31-year-old woman at 32 weeks' gestation presented with an ST segment elevation myocardial infarction with subsequent bare metal stent placement. A multidisciplinary team coordinated the delivery plan, including anticoagulation and delivery mode. Because the patient was at high risk for stent thrombosis, clopidogrel was discontinued after 4 weeks and bridged with eptifibatide for 7 days. Epti...
متن کاملCurrent antiplatelet therapy for Japanese patients with ST elevation acute myocardial infarction: J-AMI registry.
Antiplatelet therapy could prevent stent thrombosis, but may be associated with an increased risk of bleeding. Recent studies have revealed that bleeding complications are relatively frequent in patients with acute coronary syndromes. Our aim was to describe the current status of antiplatelet therapy for Japanese patients with acute myocardial infarction (AMI). The Japan AMI (J-AMI) registry is...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Monaldi Archives for Chest Disease
سال: 2019
ISSN: 2532-5264,1122-0643
DOI: 10.4081/monaldi.2019.1046